Jonathan Schechter Synaptogenix, Inc. (SNPX) insider trading activity

Jonathan Schechter is Director of Synaptogenix, Inc.. Currently has a direct ownership of 14,035 shares of SNPX, which is worth approximately $129,262. The most recent transaction as insider was on Jun 30, 2025, when has been sold 8,630 shares (Common Stock, par value $0.0001 per share) at a price of $7.85 per share, resulting in proceeds of $67,745. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14K

50.75% 3M change

50.75% 12M change

Total Value Held $129,262

JONATHAN SCHECHTER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 30 2025	SELL Payment of exercise price or tax liability	$67,745 $7.85 p/Share	8,630 Reduced 38.08%	14,035 Common Stock, par valu...
Jun 30 2025	BUY Grant, award, or other acquisition	-	21,575 Added 48.77%	22,665 Common Stock, par valu...
Dec 16 2022	SELL Open market or private sale	$23,692 $1.17 p/Share	20,250 Reduced 41.54%	28,500 Common Stock, par valu...
Jul 13 2021	BUY Grant, award, or other acquisition	-	45,000 Added 48.0%	48,750 Common Stock, par valu...

Also insider at

PMCB

PharmaCyte Biotech, Inc. Healthcare

Director